Telomere length in atherosclerosis and diabetes

Atherosclerosis

Volumn 209, Issue 1, 2010, Pages 35-38

  Salpea, Klelia D ^a   Humphries, Steve E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular disease; Diabetes; Oxidative stress; Telomere length

Indexed keywords

TELOMERASE;

AGING; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; COMORBIDITY; DIABETES MELLITUS; DNA DAMAGE; ENZYME ACTIVITY; GENETIC VARIABILITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SENESCENCE; TELOMERE;

EID: 77049086997     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.12.021     Document Type: Note

References (33)

1. Szostak J.W., and Blackburn E.H. Cloning yeast telomeres on linear plasmid vectors. Cell 29 (1982) 245-255
2. Greider C.W., and Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43 (1985) 405-413
3. Greider C.W., and Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337 (1989) 331-337
4. Olovnikov A.M. Principle of marginotomy in template synthesis of polynucleotides. Doklady Akademii nauk SSSR 201 (1971) 1496-1499
5. Blackburn E.H., Greider C.W., and Szostak J.W. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nature Medicine 12 (2006) 1133-1138
6. Allsopp R.C., and Harley C.B. Evidence for a critical telomere length in senescent human fibroblasts. Experimental Cell Research 219 (1995) 130-136
7. Sozou P.D., and Kirkwood T.B. A stochastic model of cell replicative senescence based on telomere shortening, oxidative stress, and somatic mutations in nuclear and mitochondrial DNA. Journal of Theoretical Biology 213 (2001) 573-586
8. Petersen S., Saretzki G., and von Zglinicki T. Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Experimental Cell Research 239 (1998) 152-160
9. Serra V., Grune T., Sitte N., Saretzki G., and von Zglinicki T. Telomere length as a marker of oxidative stress in primary human fibroblast cultures. Annals of the New York Academy of Sciences 908 (2000) 327-330
10. Adaikalakoteswari A., Balasubramanyam M., Ravikumar R., Deepa R., and Mohan V. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis 195 (2007) 83-89
11. Satoh M., Ishikawa Y., Takahashi Y., Itoh T., Minami Y., and Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 198 (2008) 347-353
12. Richards J.B., Valdes A.M., Gardner J.P., et al. Homocysteine levels and leukocyte telomere length. Atherosclerosis 200 (2008) 271-277
13. Chen W., Gardner J.P., Kimura M., et al. Leukocyte telomere length is associated with HDL cholesterol levels: The Bogalusa heart study. Atherosclerosis 205 (2009) 620-625
14. Olivieri F., Lorenzi M., Antonicelli R., et al. Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction. Atherosclerosis 206 (2009) 588-593
15. Salpea K.D., Talmud P.J., Cooper J.A., et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis (2009) 10.1016/j.atherosclerosis.2009.09.070
16. Samani N.J., Boultby R., Butler R., Thompson J.R., and Goodall A.H. Telomere shortening in atherosclerosis. Lancet 358 (2001) 472-473
17. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., and Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105 (2002) 1541-1544
18. Matthews C., Gorenne I., Scott S., et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circulation Research 99 (2006) 156-164
19. Brouilette S., Singh R.K., Thompson J.R., Goodall A.H., and Samani N.J. White cell telomere length and risk of premature myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 23 (2003) 842-846
20. Brouilette S.W., Moore J.S., McMahon A.D., et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369 (2007) 107-114
21. Fitzpatrick A.L., Kronmal R.A., Gardner J.P., et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. American Journal of Epidemiology 165 (2007) 14-21
22. Salpea K.D., Nicaud V., Tiret L., Talmud P.J., and Humphries S.E. The association of telomere length with paternal history of premature myocardial infarction in the European Atherosclerosis Research Study II. Journal of Molecular Medicine (Berlin, Germany) 86 (2008) 815-824
23. Brouilette S.W., Whittaker A., Stevens S.E., van der Harst P., Goodall A.H., and Samani N.J. Telomere length is shorter in healthy offspring of subjects with coronary artery disease: support for the telomere hypothesis. Heart 94 (2008) 422-425
24. Zee R.Y., Michaud S.E., and Ridker P.M. Mean telomere length and risk of incident venous thromboembolism: a prospective, nested case-control approach. Clinica Chimica Acta: International Journal of Clinical Chemistry 406 (2009) 148-150
25. Wilson W.R., Herbert K.E., Mistry Y., et al. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. European Heart Journal 29 (2008) 2689-2694
26. Sampson M.J., Winterbone M.S., Hughes J.C., Dozio N., and Hughes D.A. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 29 (2006) 283-289
27. Uziel O., Singer J.A., Danicek V., et al. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Experimental Gerontology 42 (2007) 971-978
28. Verzola D., Gandolfo M.T., Gaetani G., et al. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. American Journal of Physiology 295 (2008) F1563-1573
29. Tentolouris N., Nzietchueng R., Cattan V., et al. White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria. Diabetes Care 30 (2007) 2909-2915
30. Sampson M.J., and Hughes D.A. Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes. Diabetologia 49 (2006) 1726-1731
31. Nordfjall K., Svenson U., Norrback K.F., Adolfsson R., Lenner P., and Roos G. The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genetics 5 (2009) e1000375
32. Slagboom P.E., Droog S., and Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. American Journal of Human Genetics 55 (1994) 876-882
33. Graakjaer J., Pascoe L., Der-Sarkissian H., et al. The relative lengths of individual telomeres are defined in the zygote and strictly maintained during life. Aging Cell 3 (2004) 97-102